期刊文献+

脑膜败血伊丽莎白菌耐药性和耐药表型研究 被引量:5

Analysis of drug resistance and resistance phenotypes of Elizabethkingia meningoseptica
下载PDF
导出
摘要 目的了解临床分离脑膜败血伊丽莎白菌(EME)的耐药率并进行耐药表型分析。方法采用微量肉汤稀释法(MIC)和KB法检测30株EME对22种抗菌药物的耐药率,用纸片法、改良三维试验法进行超广谱β-内酰胺酶(ESBLs)、头孢菌素酶(Ampc)和金属β-内酰胺酶(MBL)的表型确证试验。结果 30株EME对所有β-内酰胺类药物的耐药率达70%以上,而对环丙沙星和左氧氟沙星及含酶抑制剂的哌拉西林/他唑巴坦和头孢哌酮/舒巴坦有较好的敏感性。对万古霉素和利福平耐药率分别为23.3%和16.7%。所有菌株均检出ESBLs而未检出Ampc,18株(60.0%)细菌检出产MBL。结论 EME是多药耐药的细菌,产ESBLs和MBL,其中ESBLs对β-内酰胺类药物的耐药起主要作用。临床常用于治疗革兰阴性杆菌的亚胺培南和美罗培南对EME效果差,而用于治疗革兰阳性球菌的万古霉素和利福平对该菌有治疗活性,复方新诺明、米诺环素、含酶抑制剂类、氟喹喏酮类药物是治疗的首选。 Objective To investigate drug resistance and resistance phenotypes of Elizabethkingia meningo-septica(EME).Methods The drug resistance rates of 30 strains to 22 antibiotics were detected by MIC and disk dilu-tion method.Phenotypes of extended spectrum β-lactamase(ESBLs), Ampc and metallo β-lactamase(MBL) were de-tected by disk diffusion and modified three dimension test .Results The drug resistance rates of 30 strains toβ-lactam grop drugs were above 70%, all strains were more susceptible to trimethoprim-sulfa(SXT), ciprofloxacin, levofloxacin, piperacillin/tazobactam, cefoperazone/sulbactam.The drug resistance rates to vancomycin and rifampi were 23.3%and 16.7%respectively.All the isolates were detected to have ESBLs but no Ampc , 18 strains(60.0%) had MBL.Con-clusion EME was multi-drug resistance , it can produce ESBLs and MBL .While ESBLs was most responsible for the resistance to β-lactam group drugs .EME was more resistance to imipenem and meropenem which were used to cure most of the gram negative bacilli , but more susceptible to vancomycin and rifampin which were used to cure most of the gram positive coccus.SXT, minocycline,β-lactamase inhibitor and quinolones drugs may be the best choice for its in-fection.
出处 《中国临床新医学》 2014年第12期1113-1117,共5页 CHINESE JOURNAL OF NEW CLINICAL MEDICINE
基金 广西卫生厅科研课题(编号:Z2013411)
关键词 脑膜败血伊丽莎白菌 多药耐药 超广谱Β-内酰胺酶 金属Β-内酰胺酶 Elizabethkingia meningoseptica(EME) Multi-drug resistance Extended spectrum β-lacta-mase (ESBLs) Metallo β-laetamase (MBL)
  • 相关文献

参考文献10

  • 1Issack MI, Neetoo Y. An outbreak of Elizabethkingia meuingoset,lica neonatal meningitis in Mauritius [J]. J Infect Dev CIties. 2011 . 5 (12) :834 -839.
  • 2Clinical and Laboratary Standards lnslitute. Performance standards for antimicrobial susceptibility testing; Twenty Third hfformational sup- plemcnt[ S ]. CISI document M 100-$23. Wayne. PA: Clinical and Laboratory Standards Institute,2013.33 ( 1 ) : 1 - 205.
  • 3Weaver KN, Janes tIC, Albright R, et al. Aente emergence of Eliza- bethkingia meningoseptica infeelicm among mechanically venlilaled patients in a long-term acute care facility [ J ]. Infect Comtrol Hosp Epidemiol, 2010,31(1 ) :54 -58.
  • 4Lin PY, Chert HI., Huang CT, el al. Bolfihn pr.dueti.n, use of in- travascular indwelling catheters and inappropriate antimicrobial tht.ra- py as predictors of falalily in Chseobacterium mellingt)septicum bacteraemia[ J ]. Int J Antimic]gents. 2010,36 (5) :436 - 440.
  • 5rrak V, Mathmr P, Vavgsc P, et al. Elizabt.+lhkingia miningsepti+ ca: an emerging pathogen causing meningitis in a hspitalized adult h'auma patient [ J ]. Indian J Med Microhiol, 2013,31 ( 3 ) : 293 - 295.
  • 6Gokce IK, Oncel MY, Ozdemir R, et al. Trhnethoplinl-sulfiamethox-zole treatment for meningitis owing to multidrug-rtsistant Elizabcthk- ingia meningoseptica in an extremely low-birthweight, prematurc in- fant[J]. Paediatr lnt Child Health, 2012.32 ( 3 ) : 177 - 179.
  • 7Gonzalez LJ. Vila AJ. Carbapenem resistance in Elizabethkingia meningoseptica is mediated by metallo-beta-lactamase BlaB [ J ]. Antimi- crob Agents Chemother, 2012,56 (4) : 1686 - 1692.
  • 8Thomson KS. Extended-spectrum-beta-lactamase, AmpC, and Cm bapenemase issues [ J]. J Clin Microbiol, 2010,48 (4) : 1019 - 1025.
  • 9杨佰侠,林祥宏,李涛,王中新,徐元宏.脑膜炎败血黄杆菌体外抗药活性及金属β内酰胺酶基因型研究[J].临床输血与检验,2008,10(2):114-118. 被引量:11
  • 10Livermore DM. Defining an extended-spectruzm beta-lactamase[ J]. Clin Microbiol Infect, 2008,14( S1 ) :3 - 10.

二级参考文献11

  • 1胡付品,朱德妹,吴湜,汪复,张婴元.三维试验法检测肠杆菌属细菌中超广谱β内酰胺酶和AmpC酶[J].中国抗感染化疗杂志,2004,4(5):283-286. 被引量:19
  • 2李家斌,李惠,李旭,余鑫之,马亦林,俞云松.4株产TEM型超广谱β内酰胺酶肠杆菌科细菌的研究[J].中国抗感染化疗杂志,2004,4(6):324-327. 被引量:8
  • 3张嵘,周宏伟,陈功祥.脑膜败血金黄杆菌产金属β-内酰胺酶的检测及基因型的研究[J].中华微生物学和免疫学杂志,2006,26(8):734-738. 被引量:15
  • 4Yong D, Lee K,Yum JH,et al. Imipenem-EDTA disk method for differentiation of metallo-β-lactamase-producing clinical isolates of Pseudomonas spp. and Acinetobacter spp[J]. J Clin Microbiol, 2002,40(10) : 3798.
  • 5Woodford N, Marie-France I Palepou, Babini S, et al. Carbapenemases of Chryseobacterium (Flavob-acterium) meningosepticum:distribution of blab and characterization of a novel Metallo-β-Lactamase gene,blaB3, in the type strain, NCTC 10016[J]. Antimicrob Agents Chemother, 2000,44(6) : 1448-1452.
  • 6Bellais S, Aubert D,Naas T, et al. Molecular and biochemical heterogeneity of class B Carbapenem-hydrolyzing β-Laetamases in chryseobacterium meningoseptieum[J]. Antimicrob Agents Chemother,2000,44 (7) : 1878-1886.
  • 7Shibata N,Doi Y,Yamane K,et al. PCR typing of genetic determinants for Metallo-β-Lactamases and integrases carried by gram-negative bacteria isolated in Japan,with focus on the Class 3 integron[J]. J Clin Microbiol, 2003,41 (12) : 5407-5413.
  • 8Chen GX, Zhang R, Zhou HW. Heterogeneity of metallobeta-lactamases in clinical isolates of Chryseobacterium meningosepticum from Hangzhou, China[J]. J Antimicrob Chemother, 2006,57 (4) :750-752.
  • 9Bellais S, Poirel L, Naas T, et al. Genetic-biochemical analysis and distribution of the ambler class A β-Lactamase CME-2,responsible for extended-spectrum ceph- alosporin resistance in Chryseobacterium (Flavobacterium) meningosepticum [ J ]. Antimicrob Agents Chemother, 2000,44 (1) : 1-9.
  • 10Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing, 15th informational supplement [S]. CLSI document,2005,25:1-167.

共引文献10

同被引文献43

引证文献5

二级引证文献17

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部